ctrl K

Watchlist Price Alert

TCR2 Therapeutics Inc. (TCRR)

NASDAQ: TCRR · Real-Time Price · USD

1.48

0.00 (0.00%)

At close: May 31, 2023, 8:00 PM

TCR2 Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-153.5M	-99.74M	-68.7M	-51.38M	-26.45M	-13.18M	-9.93M
Interest Income	1.94M	224K	1.74M	n/a	n/a	n/a	n/a
Pretax Income	-151.56M	-99.52M	-66.96M	-47.5M	-24.25M	-13.07M	-9.91M
Net Income	-151.82M	-99.81M	-67.12M	-47.6M	-24.25M	-13.07M	-9.91M
Selling & General & Admin	24.44M	22.5M	16.72M	13.89M	6.78M	3.61M	2.26M
Research & Development	98.64M	77.24M	51.98M	37.49M	19.67M	9.57M	7.67M
Other Expenses	30.42M	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	123.08M	99.74M	68.7M	51.38M	26.45M	13.18M	9.93M
Interest Expense	58.9M	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	123.08M	99.74M	68.7M	51.38M	26.45M	13.18M	9.93M
Income Tax Expense	261K	289K	161K	102K	2.2M	110K	15K
Shares Outstanding (Basic)	38.63M	37.94M	27.99M	21.1M	23.19M	5.13M	5.13M
Shares Outstanding (Diluted)	38.63M	37.94M	27.99M	21.1M	23.19M	5.13M	5.13M
EPS (Basic)	-3.93	-2.63	-2.4	-2.26	-1.05	-2.55	-1.93
EPS (Diluted)	-3.93	-2.63	-2.4	-2.26	-1.05	-2.55	-1.93
EBITDA	-89.62M	-96.92M	-67.11M	-50.52M	-23.83M	-12.77M	-9.7M
EBIT	-92.67M	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	63.88M	2.83M	1.59M	862K	419K	298K	220K